Evaluation of Galleria mellonella larvae for studying the virulence of Streptococcus suis

[1]  P. Finn,et al.  Putative histidine kinase inhibitors with antibacterial effect against multi-drug resistant clinical isolates identified by in vitro and in silico screens , 2016, Scientific Reports.

[2]  P. van Baarlen,et al.  A Zebrafish Larval Model to Assess Virulence of Porcine Streptococcus suis Strains , 2016, PloS one.

[3]  B. Facinelli,et al.  Recombination between Streptococcus suis ICESsu32457 and Streptococcus agalactiae ICESa2603 yields a hybrid ICE transferable to Streptococcus pyogenes. , 2015, Veterinary microbiology.

[4]  J. Corander,et al.  Genomic signatures of human and animal disease in the zoonotic pathogen Streptococcus suis , 2015, Nature Communications.

[5]  J. Nielsen,et al.  Host-pathogen Interaction at the Intestinal Mucosa Correlates With Zoonotic Potential of Streptococcus suis , 2014, The Journal of infectious diseases.

[6]  J. Wells,et al.  A naturally occurring nucleotide polymorphism in the orf2/folc promoter is associated with Streptococcus suis virulence , 2014, BMC Microbiology.

[7]  P. van Baarlen,et al.  Control of Competence for DNA Transformation in Streptococcus suis by Genetically Transferable Pherotypes , 2014, PloS one.

[8]  R. Faustoferri,et al.  β-Phosphoglucomutase contributes to aciduricity in Streptococcus mutans. , 2014, Microbiology.

[9]  P. van Baarlen,et al.  Carbohydrate Availability Regulates Virulence Gene Expression in Streptococcus suis , 2014, PloS one.

[10]  P. Coote,et al.  Evaluation of Galleria mellonella larvae for measuring the efficacy and pharmacokinetics of antibiotic therapies against Pseudomonas aeruginosa infection. , 2014, International journal of antimicrobial agents.

[11]  Jianguo Xu,et al.  Streptococcus suis, an important pig pathogen and emerging zoonotic agent—an update on the worldwide distribution based on serotyping and sequence typing , 2014, Emerging Microbes & Infections.

[12]  Yuan-Ying Jiang,et al.  Using Galleria mellonella-Candida albicans infection model to evaluate antifungal agents. , 2013, Biological & pharmaceutical bulletin.

[13]  K. Kavanagh,et al.  An analysis of the structural and functional similarities of insect hemocytes and mammalian phagocytes , 2013, Virulence.

[14]  S. Wiles,et al.  Galleria mellonella larvae as an infection model for group A streptococcus , 2013, Virulence.

[15]  J. Wells,et al.  Immunomodulatory Effects of Streptococcus suis Capsule Type on Human Dendritic Cell Responses, Phagocytosis and Intracellular Survival , 2012, PloS one.

[16]  D. Rozen,et al.  A Streptococcus pneumoniae infection model in larvae of the wax moth Galleria mellonella , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[17]  M. Segura.  Fisher scientific award lecture - the capsular polysaccharides of Group B Streptococcus and Streptococcus suis differently modulate bacterial interactions with dendritic cells. , 2012, Canadian journal of microbiology.

[18]  N. Fittipaldi,et al.  Virulence factors involved in the pathogenesis of the infection caused by the swine pathogen and zoonotic agent Streptococcus suis. , 2012, Future microbiology.

[19]  P. Coote,et al.  Wax moth larva (Galleria mellonella): an in vivo model for assessing the efficacy of antistaphylococcal agents. , 2011, The Journal of antimicrobial chemotherapy.

[20]  C. Schultsz,et al.  Genetic diversity of Streptococcus suis isolates as determined by comparative genome hybridization , 2011, BMC Microbiology.

[21]  M. Gottschalk,et al.  Characterization of porcine dendritic cell response to Streptococcus suis , 2011, Veterinary research.

[22]  G. Salekdeh,et al.  Identification of genes differentially expressed during interaction of Mexican lime tree infected with "Candidatus Phytoplasma aurantifolia" , 2011, BMC Microbiology.

[23]  M. Gottschalk,et al.  Streptococcus suis: a new emerging or an old neglected zoonotic pathogen? , 2010, Future microbiology.

[24]  Constance Schultsz,et al.  Streptococcus suis: an emerging human pathogen. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  J. Farrar,et al.  Streptococcus suis meningitis in adults in Vietnam. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  S. Rivest,et al.  Streptococcus suis Serotype 2, an Important Swine and Human Pathogen, Induces Strong Systemic and Cerebral Inflammatory Responses in a Mouse Model of Infection1 , 2007, The Journal of Immunology.

[27]  M. Gottschalk,et al.  Streptococcus suis infections in humans: the Chinese experience and the situation in North America , 2007, Animal Health Research Reviews.

[28]  Weizhong Yang,et al.  Streptococcal Toxic Shock Syndrome Caused by Streptococcus suis Serotype 2 , 2006, PLoS medicine.

[29]  Khuanchai Supparatpinyo,et al.  Streptococcus suis infection: a series of 41 cases from Chiang Mai University Hospital. , 2006, The Journal of infection.

[30]  Weizhong Yang,et al.  Human Streptococcus suis Outbreak, Sichuan, China , 2006, Emerging infectious diseases.

[31]  Weizhong Yang,et al.  Streptococcal Toxic Shock Syndrome Caused by Streptococcus suis Serotype 2 , 2006, PLoS Medicine.

[32]  P. Nunthapisud,et al.  Streptococcus suis meningitis in Thailand. , 2004, The Southeast Asian journal of tropical medicine and public health.

[33]  M. Gottschalk,et al.  Multiplex PCR Assay for Detection of Streptococcus suis Species and Serotypes 2 and 1/2 in Tonsils of Live and Dead Pigs , 2004, Journal of Clinical Microbiology.

[34]  K. Kavanagh,et al.  Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens. , 2004, FEMS microbiology reviews.

[35]  H. Jensen,et al.  Bacterial colonization and invasion in pigs experimentally exposed to Streptococcus suis serotype 2 in aerosol. , 2002, Journal of veterinary medicine. B, Infectious diseases and veterinary public health.

[36]  M. Salzet,et al.  Vertebrate innate immunity resembles a mosaic of invertebrate immune responses. , 2001, Trends in immunology.

[37]  D. Maskell,et al.  Generation and Characterization of a Defined Mutant of Streptococcus suis Lacking Suilysin , 2001, Infection and Immunity.

[38]  P. Valentin-Weigand,et al.  Relatedness of Streptococcus suisIsolates of Various Serotypes and Clinical Backgrounds as Evaluated by Macrorestriction Analysis and Expression of Potential Virulence Traits , 2001, Journal of Clinical Microbiology.

[39]  M. Schweiger,et al.  Septicaemia in a pig-farm worker , 2001, The Lancet.

[40]  Hilde E. Smith,et al.  Distribution of capsular types and production of muramidase-released protein (MRP) and extracellular factor (EF) of Streptococcus suis strains isolated from diseased pigs in seven European countries. , 2000, Veterinary microbiology.

[41]  M. Smits,et al.  Identification and Characterization of thecps Locus of Streptococcus suis Serotype 2: the Capsule Protects against Phagocytosis and Is an Important Virulence Factor , 1999, Infection and Immunity.

[42]  M. Chengappa,et al.  Streptococcus Suis: Past and Present , 1997, Veterinary Research Communications.

[43]  Hilde E. Smith,et al.  Characterization of virulence of the Streptococcus suis serotype 2 reference strain Henrichsen S 735 in newborn gnotobiotic pigs. , 1996, Veterinary microbiology.

[44]  M. Chengappa,et al.  Partial characterization of Streptococcus suis type 2 hemolysin , 1994, Journal of clinical microbiology.

[45]  J. Arends,et al.  Differences in virulence between two strains of Streptococcus suis type II after experimentally induced infection of newborn germ-free pigs. , 1989, American journal of veterinary research.

[46]  R. Faustoferri,et al.  b-Phosphoglucomutase contributes to aciduricity in Streptococcus mutans , 2014 .

[47]  P. Coote,et al.  Utility of Greater Wax Moth Larva (Galleria mellonella) for Evaluating the Toxicity and Efficacy of New Antimicrobial Agents. , 2012, Advances in applied microbiology.

[48]  H. Zanen,et al.  Meningitis caused by Streptococcus suis in humans. , 1988, Reviews of infectious diseases.